Translation to Industry

CMAC’s research programme and translation to industry vision are informed through close collaboration with our industrial partners, aiming to provide answers to industry-relevant questions, and to drive technology transformation and implementation.

INDUSTRY ENGAGEMENT

Translatable Technologies Mapped onto the CMAC Technology Translation Road-Map

CMAC continues to expand and develop the collaborations across large pharma (Tier 1s), large corporations and SMEs in the technology field (Tier 2s), and academia to provide an immersive ecosystem of pre-competitive research knowledge sharing and process improvement. A stage-gate process has been instituted as a means of managing technologies from low to high Technology Readiness Levels (TRL).

Flowchart representing technology development stages from problem definition to validated prototypes, with translation impact increasing at each level, from TRL 0 to TRL 6.

A person's hand reaching into his pocket and their hand is grabbing an item from a pharmacy or medicine cabinet with various boxes of medication and supplies on the shelves.

Exemplary Translation to Industry

CMAC is continuing to strengthen its industry engagement strategy into 2021 and beyond. Driven by our mission to transform medicines manufacture, development time and cost to market, we are maximising our relationships with large pharma, SMEs, and academic stakeholders within our ecosystem to lead the process of solving real-world challenges while growing and enhancing our long-term sustainability.

Translating for Impact

Young woman scientist with curly hair wearing safety glasses and gloves, carefully handling a test tube with blue liquid in a laboratory, surrounded by lab equipment.

PhD Placements with Industry Partners

PhD placements remain a successful translation pathway for delivering quick-win tangible benefits to our industrial partners. The placements enable value to be gained by both the companies and researchers.

Topic areas included:

Developed workflows for solid form screening and habit modification
Advanced Characterisation of amorphous content using SAXS
Quality optimisation through experimental design and 2D population balance modelling
Understanding and controlling impurities in crystallisation and isolation
Process understanding of hot melt extrusion

More about phd Training

Our Industrial Members

The continued support and engagement of the Tier 1 Industry partners has been at the core of CMAC’s success. Within the consortium of 7 Tier 1 partners from the global pharmaceutical industry, there is an opportunity to collaborate in a pre-competitive manner to co-develop a programme of research, and lead transformation and innovation in advanced pharmaceutical manufacturing. Industrial partners provide coordinated and sustained mentoring, direction, validation and support across the wider CMAC organisation.